It has been observed in some experimental setups that animal subjects exposed to Ipamorelin experienced an approximate 15% increase in body weight
Location: Plainsboro, New JerseyWarning Letter Date: September 9, 2025FDA Department Issuing Warning: Center for Drug Evaluation and Research (CDER)Type of Warning: False & Misleading Claims/Misbranded DrugsSubject of Violation: An Oprah Special: Shame, Blame, and the Weight Loss Revolution, regarding Wegovy (semaglutide) injection, for subcutaneous use, Ozempic (semaglutide) injection, for subcutaneous use, and Victoza (liraglutide) injection, for subcutaneous use.FDA Warning: In the program, which aired on television in 2024 and until recently was available continuously on the ABC website and through various streaming services, Novo Nordisk promoted Wegovy, Ozempic, and Victoza in a manner that failed to present the serious risks of these drug products in a truthful and nonmisleading manner
Zhou W, Chen G, Chen D, Ye H, Zeng X
Thyroid Supplement Support with L-Carnitine for Cats
Clinical providers and self-injectors who have practiced proper technique report markedly fewer painful experiences
No pharmacologic agent targeting physiologic traits has proven to be sufficiently effective enough to replace standard therapies
